D
Désirée van der Heijde
Researcher at Leiden University Medical Center
Publications - 764
Citations - 57315
Désirée van der Heijde is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Ankylosing spondylitis & Medicine. The author has an hindex of 107, co-authored 674 publications receiving 48488 citations. Previous affiliations of Désirée van der Heijde include Leiden University & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen,Robert Landewé,Ferdinand C. Breedveld,Maya H Buch,Maya H Buch,Gerd R Burmester,Maxime Dougados,Paul Emery,Paul Emery,Cécile Gaujoux-Viala,Laure Gossec,Jackie L Nam,Jackie L Nam,Sofia Ramiro,Kevin L. Winthrop,Maarten de Wit,Daniel Aletaha,Neil Betteridge,Johannes W. J. Bijlsma,Maarten Boers,Frank Buttgereit,Bernard Combe,Maurizio Cutolo,Nemanja Damjanov,Johanna M. W. Hazes,Marios Kouloumas,Tore K Kvien,Xavier Mariette,Karel Pavelka,Piet L. C. M. van Riel,Andrea Rubbert-Roth,Marieke Scholte-Voshaar,David Scott,T. Sokka-Isler,John B. Wong,Désirée van der Heijde +35 more
TL;DR: These recommendations intend informing rheumatologists, patients, national rheumology societies, hospital officials, social security agencies and regulators about EULAR's most recent consensus on the management of RA, aimed at attaining best outcomes with current therapies.
Journal Article
Treating rheumatoid arthritis to target: recommendations of an international task force (vol 69, pg 631, 2010)
TL;DR: In this article, a task force of rheumatologists and a patient developed a set of recommendations on the basis of evidence derived from a systematic literature review and expert opinion; these were subsequently discussed, amended and voted upon by >60 experts from various regions of the world in a Delphi-like procedure.
Journal ArticleDOI
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson,David T. Felson,Josef S Smolen,George A. Wells,Bi Zhang,Lilian H D van Tuyl,Julia Funovits,Daniel Aletaha,Cornelia F Allaart,Joan M. Bathon,Joan M. Bathon,Stefano Bombardieri,Peter Brooks,Andrew K Brown,Marco Matucci-Cerinic,Hyon K. Choi,Bernard Combe,Maarten de Wit,Maxime Dougados,Paul Emery,Daniel E. Furst,Juan J. Gomez-Reino,Gillian A. Hawker,Edward C. Keystone,Dinesh Khanna,John R. Kirwan,Tore K Kvien,Robert Landewé,Joachim Listing,Kaleb Michaud,Emilio Martín-Mola,Pamela Montie,Theodore Pincus,Pamela Richards,Jeffrey Siegel,Jeffrey Siegel,Lee S. Simon,Tuulikki Sokka,Vibeke Strand,Peter Tugwell,Alan Tyndall,Désirée van der Heijde,S. M. M. Verstappen,Barbara White,Frederick Wolfe,Angela Zink,Maarten Boers +46 more
TL;DR: It is proposed that a patient's RA can be defined as being in remission based on one of two definitions: (1) when scores on the tender joint count, swollen joint counts, CRP level, and patient global assessment are all ≤1, or (2) when the score on the Simplified Disease Activity Index is ≤3.
Journal ArticleDOI
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Désirée van der Heijde,Sofia Ramiro,Robert Landewé,Xenofon Baraliakos,Filip Van den Bosch,Alexandre Sepriano,Alexandre Sepriano,Andrea Regel,Adrian Ciurea,Hanne Dagfinrud,Maxime Dougados,Maxime Dougados,Floris A. van Gaalen,Pál Géher,Irene E. van der Horst-Bruinsma,Robert D. Inman,Merryn Jongkees,Uta Kiltz,Tore K Kvien,Pedro Machado,Helena Marzo-Ortega,Anna Molto,Anna Molto,Victoria Navarro-Compán,Salih Ozgocmen,Fernando Pimentel-Santos,John D. Reveille,Martin Rudwaleit,Martin Rudwaleit,J. Sieper,Percival D. Sampaio-Barros,Dieter Wiek,Jürgen Braun +32 more
TL;DR: The 2016 Assessment of SpondyloArthritis international Society-EULAR recommendations provide up-to-date guidance on the management of patients with axSpA and three overarching principles and 13 recommendations deal with surgery and spinal fractures.
Journal ArticleDOI
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial
E. William St. Clair,Désirée van der Heijde,Josef S Smolen,Ravinder N. Maini,Joan M. Bathon,Paul Emery,Edward C. Keystone,Michael Schiff,Joachim R. Kalden,Ben Wang,Kimberly Dewoody,Roberta Weiss,Daniel Baker +12 more
TL;DR: For patients with active RA in its early stages, combination therapy with MTX and infliximab provides greater clinical, radiographic, and functional benefits than treatment withMTX alone.